Aleksandra M. Orlova

Aleksandra M. Orlova

Auto-generated profile, based on publicly available information

Aleksandra M. Orlova

Soft Matter Synthesis Laboratory – Institute for Biological Interfaces III (IGB‐3) Karlsruhe Institute of Technology Karlsruhe Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in European Polymer Journal
Verified
Journal Article
Closed access
TKTimofey I. Kolesnikov
Timofey I. Kolesnikov
AOAlexandra M. Orlova
Alexandra M. Orlova
ATAnna Y. Tsegelskaya
Anna Y. Tsegelskaya
GCGeorgij V. Cherkaev
Georgij V. Cherkaev
AKAlexander S. Kechekyan
Alexander S. Kechekyan
AKAlexander A. Kuznetsov
Alexander A. Kuznetsov

24 August 2022 in Polymer
Verified
Journal Article
Closed access
AOAlexandra M. Orlova
Alexandra M. Orlova
AAAlexander Yu Alentiev
Alexander Yu Alentiev
TKTimofey I. Kolesnikov
Timofey I. Kolesnikov
ATAnna Yu Tsegelskaya
Anna Yu Tsegelskaya
KMKristina Z. Monakhova
Kristina Z. Monakhova
AKAlexander A. Kuznetsov
Alexander A. Kuznetsov

20 December 2021 in Polymer Science, Series B
Verified
Journal Article
Closed access
PDF file
AOA. M. Orlova
A. M. Orlova
ATA. Yu. Tsegelskaya
A. Yu. Tsegelskaya
TKT. I. Kolesnikov
T. I. Kolesnikov
IAI. G. Abramov
I. G. Abramov
AKA. A. Kuznetsov
A. A. Kuznetsov
A novel monomer for the synthesis of polyimides, 5-methyl-1,3-phenylene-bis-4-oxyphthalic acid dianhydride was developed. The synthesis was carried out in three stages: the reaction of nucleophilic nitro substitution of 4-nitrophthalonitrile with 5‑methylresorcinol (orcinol) potassium salt and subsequent hydrolysis of the nitrile groups have afforded 5‑methyl-1,3-phenylene-bis-4-oxyphthalic acid, dehydration of which has given the corresponding dianhydride. A series of new thermoplastic high molecular weight polyetherimides based on 5-methyl-1,3-phenylene-bis-4-oxyphthalic acid dianhydride and several aromatic diamines of various structures were synthesized by the method of one-stage catalytic polycondensation in a benzoic acid melt. Inherent viscosity and weight-average molecular mass of the polyetherimides have been of 0.28‒1.20 dL/g and (33‒114) × 103, respectively. The polyetherimides have been soluble in chloroform, THF, DMF, DMAA, N-methylpyrrolidone, and DMSO and have revealed film-forming properties. According to the DSC and wide-angle X-ray scattering data, the polyetherimides have been found completely amorphous, the glass transition temperature being in the 185–307°C range.

14 October 2025 in Macromolecular Rapid Communications
Verified
Journal Article
Open access
NSNoël René Schneider
Noël René Schneider
AOAleksandra M. Orlova
Aleksandra M. Orlova
NKNuwanthika Dilrukshi Kumarage
Nuwanthika Dilrukshi Kumarage
PTPatrick Theato
Patrick Theato
KNKevin Neumann
Kevin Neumann
Rising hypersensitivity to PEG and accelerated blood clearance highlight the need for alternative charge‐neutral hydrophilic polymers. Poly(ylide)s represent a class of hydrophilic polymers with biocompatibility and antifouling properties. Here, we explore poly(iminopyridinium ylide) (PIPY) as a versatile nano‐ and biomedical building block. PIPY is synthesized via post‐polymerization modification of poly(pentafluorophenyl acrylate), maintaining a narrow molecular weight distribution. PIPY's structure was confirmed by NMR, FTIR, and SEC. PIPY is soluble in water, saline, MeOH, and DMSO, and remains stable from strongly acidic to physiological pH. Critical aggregation concentration and DOSY NMR measurements indicate an anti‐polyelectrolyte effect and minimal responsiveness to apolar environments, respectively. Notably, PIPY exhibits minimal, entropically driven binding to biomolecules such as bovine serum albumin and lysozyme. This low interaction is critical for its ability to prevent insulin fibrillation upon heating, suggesting utility as a protein‐stabilizing matrix. These combined properties position PIPY as a promising material for future bio‐ and nanomedical applications.